Analytic Investors’s Enzo Biochem, Inc. ENZ Stock Holding History

Analytic Investors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$431K	Buy	+84,556	New	+$505K	﹤0.01%	495

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Analytic Investors's ENZ Position: Q3 2016 in Review

Analytic Investors opened a new position in Enzo Biochem, Inc. (ENZ) in Q3 2016: 84,556 shares worth $431K. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings.

111 funds tracked by Wall St. Rank hold ENZ as of Q3 2016.

Analytic Investors held 84,556 shares of Enzo Biochem, Inc. worth $431K as of Q3 2016.
Enzo Biochem, Inc. was a new Analytic Investors position in Q3 2016.
Enzo Biochem, Inc. made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #495 holding.
111 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.